F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) Short Interest Up 115.9% in July

F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) saw a significant growth in short interest during the month of July. As of July 15th, there was short interest totaling 22,041 shares, a growth of 115.9% from the June 30th total of 10,208 shares. Approximately 0.8% of the company’s stock are sold short. Based on an average daily volume of 9,029 shares, the short-interest ratio is currently 2.4 days.

Institutional Trading of F/m Emerald Life Sciences Innovation ETF

An institutional investor recently raised its stake in F/m Emerald Life Sciences Innovation ETF stock. Hunter Associates Investment Management LLC increased its position in F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) by 8.3% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 49,739 shares of the company’s stock after purchasing an additional 3,831 shares during the period. Hunter Associates Investment Management LLC owned 1.86% of F/m Emerald Life Sciences Innovation ETF worth $1,736,000 at the end of the most recent quarter.

F/m Emerald Life Sciences Innovation ETF Stock Up 2.7%

Shares of NASDAQ:LFSC traded up $1.22 during trading on Thursday, hitting $46.15. 10,955 shares of the company were exchanged, compared to its average volume of 4,791. F/m Emerald Life Sciences Innovation ETF has a 12-month low of $24.22 and a 12-month high of $47.68. The firm’s 50 day moving average price is $42.64 and its 200-day moving average price is $38.41.

About F/m Emerald Life Sciences Innovation ETF

The F/M Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed ETF that targets US health care and biotechnology companies identified to have promising life sciences opportunities. LFSC was launched on Oct 31, 2024 and is issued by F/m Investments.